ArticleJournal of magnetic resonance imaging : JMRI2026
Prognostic Value of a Cardiac Magnetic Resonance-Derived Left Atrioventricular Coupling Index From Routine Cine Images in Dilated Cardiomyopathy: A Multicenter Study.
Article in Journal of magnetic resonance imaging : JMRI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial for "Prognostic Value of a Cardiac Magnetic Resonance-Derived Left Atrioventricular Coupling Index From Routine Cine Images in Dilated Cardiomyopathy: A Multicenter Study".Journal of magnetic resonance imaging : JMRI · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAccurate risk stratification in dilated cardiomyopathy (DCM) is challenging. Conventional markers like left ventricular ejection fraction (LVEF) and late gadolinium enhancement (LGE) fail to fully capture the pathophysiological interplay between left atrial (LA) and left ventricular (LV) remodeling. PURPOSE: To determine the prognostic value of a cardiac MRI-derived left atrioventricular coupling index (LACI) to predict adverse outcomes in DCM and assess its incremental utility beyond conventional markers. STUDY TYPE: Retrospective. POPULATION: 403 patients with DCM from two centers, randomly split into a training set (n = 282, 70%) for model development and an internal validation set (n = 121, 30%). FIELD STRENGTH/SEQUENCE: Balanced steady-state free precession cine and inversion-recovery prepared fast gradient-echo (LGE) sequences at 1.5T and 3.0T. ASSESSMENT: LACI was quantified as (LA minimal volume/LV end-diastolic volume) × 100% from routine cine images. LA/LV volumes, function, LGE, and global longitudinal strain (GLS) were assessed by blinded radiologists. The primary endpoint was a composite of all-cause mortality or heart failure hospitalization. STATISTICAL TESTS: Student's t-test, Mann-Whitney U test, chi-square test, Spearman's correlation, Cox regression, Kaplan-Meier analysis with log-rank test, receiver operating characteristic analysis, C-index, net reclassification improvement (NRI). A two-sided p value < 0.05 was significant.
resultsOver a median 43.6-month follow-up, 97 patients (24.1%) reached the primary endpoint. In the training set, elevated LACI (≥ 45.75%) was the strongest independent predictor (adjusted hazard ratio [HR] = 3.485, 95% CI 1.821-6.667). The LACI-enhanced model (including NYHA class, LGE, GLS) achieved a C-index of 0.804 (95% CI 0.774-0.835) in the training set, which remained robust in the validation set (C-index = 0.824, 95% CI 0.751-0.897). Adding LACI to the baseline model significantly improved reclassification (continuous NRI = 0.102, 95% CI 0.043-0.161). DATA
conclusionLACI derived from routine cine images is strongly and independently associated with adverse outcomes in DCM and provides significant incremental prognostic value beyond established markers, supporting its potential as a practical risk stratification tool. EVIDENCE LEVEL: 3. TECHNICAL EFFICACY: Stage 5.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.